Traders can buy the stock at this level for an upside target of Rs 5,200-5,500 in the next 6-8 months. We recommend buying at this level and more on dips to Rs 4,350 with a stop loss of Rs 4,200, on a weekly closing basis.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.